Vaxart, Inc. - Common Stock

1.21 USD
-0.04 (-3.20%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Vaxart, Inc. - Common Stock stock is up 3.42% since 30 days ago. The next earnings date is Mar 18, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 50% of the previous 50 March’s closed higher than February. In the last 2 Unusual Options Trades, there were 2 CALLs.

Options Flow Last 10
Date & Time Expiration Date Strike Price Trade Type Size Open Interest
28 Feb 20:36 17 Jan, 2025 1.50 CALL 500 46
28 Feb 20:38 17 Jan, 2025 1.50 CALL 500 46

About Vaxart, Inc. - Common Stock

Vaxart, Inc. engages in the discovery and development of oral recombinant protein vaccines based on its proprietary oral vaccine platform. The company's product pipeline includes norovirus vaccine, an oral tablet vaccine, which is in a Phase Ib clinical trial. It is also developing therapeutic vaccines for cervical cancer and dysplasia caused by human papillomavirus.